Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1077-1077
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 321
Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19
Brian M. Clemency, Renoj Varughese, Yaneicy Gonzalez‐Rojas, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 1, pp. 42-42
Open Access | Times Cited: 91
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 292-311
Closed Access | Times Cited: 25
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 20
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
Berislav Bošnjak, Ivan Odak, Joana Barros‐Martins, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
Innovations and development of Covid-19 vaccines: A patent review
Ahmed Subeh Alshrari, Shuaibu Abdullahi Hudu, Mohd Imran, et al.
Journal of Infection and Public Health (2021) Vol. 15, Iss. 1, pp. 123-131
Open Access | Times Cited: 44
Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect
Aline Oliveira da Siliva de Barros, Suyene Rocha Pinto, Sara Rhaissa Rezende dos Reis, et al.
Journal of nanostructure in chemistry (2022) Vol. 13, Iss. 2, pp. 263-281
Open Access | Times Cited: 25
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
Gokben Sahin, Özlem Akbal Dağıstan, Meltem Culha, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 10, pp. 2652-2661
Open Access | Times Cited: 25
Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
Sagar R. Pardeshi, Eknath Kole, Harshad S. Kapare, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2632-2632
Open Access | Times Cited: 25
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
Tushar Saha, Miguel E. Quiñones‐Mateu, Shyamal C. Das
International Journal of Pharmaceutics (2022) Vol. 624, pp. 122042-122042
Open Access | Times Cited: 24
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19
Shohreh Alipour, Laleh Mahmoudi, Fatemeh Ahmadi
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 705-715
Open Access | Times Cited: 23
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Closed Access | Times Cited: 13
ACE2 Receptor‐Targeted Inhaled Nanoemulsions Inhibit SARS‐CoV‐2 and Attenuate Inflammatory Responses
H Wang, Shuang Luo, Mingxin Xie, et al.
Advanced Materials (2024) Vol. 36, Iss. 14
Closed Access | Times Cited: 3
Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs)
Alaa S. Tulbah, Wing‐Hin Lee
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1059-1059
Open Access | Times Cited: 28
Emerging small molecule antivirals may fit neatly into COVID-19 treatment
Caroline Fenton, Susan J. Keam
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 3, pp. 112-126
Open Access | Times Cited: 19
Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection
Valentina Ruggiero, Rita Patrizia Aquino, Pasquale Del Gaudio, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1135-1135
Open Access | Times Cited: 19
Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection
Daryll Vanover, Chiara Zurla, Hannah E. Peck, et al.
Advanced Science (2022) Vol. 9, Iss. 34
Open Access | Times Cited: 17
Liposomal drug delivery to the lungs: a post covid-19 scenario
Sivadas Swathi Krishna, M. S. Sudheesh, Vidya Viswanad
Journal of Liposome Research (2023) Vol. 33, Iss. 4, pp. 410-424
Closed Access | Times Cited: 9
Effects of Essential Oils and Fragrant Compounds on Appetite: A Systematic Review
Nhi Phuc Khanh Nguyen, Khoa Nguyen Tran, Ly Thi Huong Nguyen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7962-7962
Open Access | Times Cited: 8
Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 14
Dissolution and Absorption of Inhaled Drug Particles in the Lungs
Basanth Babu Eedara, Rakesh Bastola, Shyamal C. Das
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2667-2667
Open Access | Times Cited: 12
What Happens to the Immune System after Vaccination or Recovery from COVID-19?
Bruna Tiaki Tiyo, G. Schmitz, Marina Mazzilli Ortega, et al.
Life (2021) Vol. 11, Iss. 11, pp. 1152-1152
Open Access | Times Cited: 16
PID-based with Odometry for Trajectory Tracking Control on Four-wheel Omnidirectional Covid-19 Aromatherapy Robot
Iswanto Iswanto, Alfian Ma’arif, Nia Maharani Raharja, et al.
Emerging Science Journal (2021) Vol. 5, pp. 157-181
Open Access | Times Cited: 16
Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1—7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers
Wafaa Alabsi, María F. Acosta, Fahad Al‐Obeidi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1278-1278
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top